Skip to main content
Article
Phosphotyrosine profiling identifies ephrin receptor A2 as a potential therapeutic target in esophageal squamous-cell carcinoma.
Proteomics (2015)
  • Nazia Syed, Pondicherry University
  • Mustafa A. Barbhuiya, Johns Hopkins University School of Medicine
  • Sneha M. Pinto, Manipal University
  • Raja Sekhar Nirujogi, Pondicherry University
  • Santosh Renuse, Amrita Vishwa Vidyapeetham
  • Keshava K. Datta, KIIT University
  • Aafaque Ahmad Khan, KIIT University
  • Kotteazeth Srikumar, Pondicherry University
  • T. S. Keshava Prasad, Manipal University
  • M. Vijaya Kumar, Kidwai Memorial Institute of Oncology
  • Rekha Vijay Kumar, Kidwai Memorial Institute of Oncology
  • Aditi Chatterjee, Institute of Bioinformatics, International Technology Park Bangalore India
  • Akhilesh Pandey, McKusick‐Nathans Institute of Genetic Medicine Johns Hopkins University School of Medicine Baltimore MD, USA
  • Harsha Gowda, Institute of Bioinformatics, International Technology Park Bangalore India
Disciplines
Publication Date
January 1, 2015
DOI
10.1002/PMIC.201400379
Citation Information
Nazia Syed, Mustafa A. Barbhuiya, Sneha M. Pinto, Raja Sekhar Nirujogi, et al.. "Phosphotyrosine profiling identifies ephrin receptor A2 as a potential therapeutic target in esophageal squamous-cell carcinoma." Proteomics Vol. 15 (2015) p. 374 - 382
Available at: http://works.bepress.com/mustafa-barbhuiya/23/